Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 22, 2021

SELL
$23.99 - $38.59 $346,991 - $558,165
-14,464 Closed
0 $0
Q1 2021

Apr 22, 2021

BUY
$32.6 - $37.82 $89,128 - $103,399
2,734 Added 23.31%
14,464 $510,000
Q4 2020

Jan 27, 2021

SELL
$24.99 - $38.45 $8,746 - $13,457
-350 Reduced 2.9%
11,730 $451,000
Q3 2020

Oct 23, 2020

SELL
$29.04 - $37.49 $749,232 - $967,242
-25,800 Reduced 68.11%
12,080 $398,000
Q2 2020

Jul 24, 2020

BUY
$20.16 - $34.84 $21,369 - $36,930
1,060 Added 2.88%
37,880 $1.32 Million
Q1 2020

Apr 22, 2020

SELL
$16.59 - $34.94 $117,706 - $247,899
-7,095 Reduced 16.16%
36,820 $855,000
Q4 2019

Jan 24, 2020

SELL
$22.24 - $27.56 $29,690 - $36,792
-1,335 Reduced 2.95%
43,915 $1.1 Million
Q3 2019

Oct 30, 2019

BUY
$25.56 - $36.1 $1.16 Million - $1.63 Million
45,250 New
45,250 $1.23 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.